Fed. Circ. Upholds Ruling Nixing AbbVie Antibody Patents
The Federal Circuit on Tuesday affirmed a lower court's ruling that two antibody patents that AbbVie Inc. accused Johnson & Johnson unit Janssen Biotech Inc.'s psoriasis treatment Stelara of infringing are...To view the full article, register now.
Already a subscriber? Click here to view full article